—

Siegfried Holding Ltd (SFZN.SW) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for SFZN.SW, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 61/100 · S&P 500 fund at 75, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-06
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 98th percentile of the window, +5.7% over 20 sessions. Factor regime → 2026-10-06
  • Sector × region Health care in Europe: −1.2% week · −3.2% month · −6.1% quarter · +2.3% yearThe Sector Engine cell this name lives in, from EXV4.XETRA; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-10-06
  • Sovereign pressure Index 0.74 · up 0.17 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-06
Who it is priced against Drug Manufacturers - Specialty & Generic · 8 names with week and year-to-date

Peer group

Drug Manufacturers - Specialty & Generic

Names in the same industry from the Closelooknet universe; scored names rank on their Closelooknet score, the rest on trend state.

Compared against SFZN.SW on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Siegfried Holding Ltd

SFZN.SW in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Siegfried Holding is a Swiss contract manufacturer that develops and produces active pharmaceutical ingredients and finished drug products for other pharmaceutical companies. Its work spans custom chemical synthesis, sterile fill-and-finish, inhalation and oral dosage forms, and manufacturing of viral vectors for gene therapy. It is based in Zofingen, Switzerland, and operates as an outsourced production partner to drugmakers worldwide.
Where it sits in the stack
Siegfried holds no seat in Rubin, our AI compute index, or in Halo; it sits outside the diary's AI-linked sleeves entirely. It is tracked instead as a pharmaceutical contract manufacturer within the healthcare sector of our wider universe, not against any build-out layer.
Who it is priced against
Closelooknet's peer group holds no comparison set for this name. The market most often sets it beside Lonza, the larger contract manufacturer active in similar drug-substance and drug-product work.
Why Closelooknet tracks it
Siegfried carries no index seat and no Closelooknet score; the score-building process has not started for this name. The diary has not quoted it in any edition so far, and it appears in no Rubin or Halo reading.
What the diary watches
The diary watches whether demand for gene-therapy and viral-vector manufacturing capacity keeps rising, since that would test how a contract manufacturer scales its production alongside larger pharmaceutical clients.

Siegfried Holding Ltd (SFZN.SW) trades on the SW exchange in Switzerland, classified under Healthcare.

The Closelooknet company score reads 42/100 composite (momentum 28, quality 45, valuation 55) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Dividends and capital return trailing yield 0.57%, annual · buybacks 1 m CHF in FY2025

Dividends and capital return

What SFZN.SW pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 0.40 CHF per share · a 0.57% yield on the 2026-10-06 close 1 distribution, paid once a year 2026-10-06
  • Last distribution 0.40 CHF per share as the price series records it, within days of the ex-date 2026-04-28
  • By calendar year 2026: 0.40 CHF to date first distribution recorded in the three-year window: 2026-04-28
  • Dividends paid, FY2025 17 m CHF 17% of earnings
  • Buybacks, FY2025 1 m CHF 0.0% of today's market value
  • Share count +0.8% in FY2025 8 m CHF of stock-based compensation in the year
  • Capital returned 18 m CHF · 180% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-10-07

Quick answers

What is Siegfried Holding Ltd (SFZN.SW)?

Siegfried Holding Ltd trades as SFZN.SW on the SW exchange (Switzerland) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-10-07.

Is SFZN.SW in a Closelooknet index?

Not currently — Siegfried Holding Ltd is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-10-07.

What is Siegfried Holding Ltd's Closelooknet composite score?

42 out of 100, with momentum 28, quality 45 and valuation 55 sub-scores, as of 2026-10-07. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does SFZN.SW trade against its moving averages?

Mixed moving-average stack: Trades -5.4% vs the 50-day and -9.7% vs the 200-day average, 30.4% below the 52-week high and +8.1% off the 52-week low. Computed from daily closes. As of 2026-10-06 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Siegfried Holding Ltd compare with its peers?

Against its peer group (Drug Manufacturers - Specialty & Generic), Siegfried Holding Ltd (SFZN.SW) sits 30.4% below its 52-week high, 5.4% below its 50-day average; Laboratorios Farmaceuticos ROVI (ROVI.MC) is 31.8% below, Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is 4.2% below, Almirall S.A. (ALM.MC) is 26.2% below. Put any of them next to SFZN.SW in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

What does Siegfried Holding Ltd do?

Siegfried Holding is a Swiss contract manufacturer that develops and produces active pharmaceutical ingredients and finished drug products for other pharmaceutical companies. Its work spans custom chemical synthesis, sterile fill-and-finish, inhalation and oral dosage forms, and manufacturing of viral vectors for gene therapy. It is based in Zofingen, Switzerland, and operates as an outsourced production partner to drugmakers worldwide. Closelooknet's peer group holds no comparison set for this name. The market most often sets it beside Lonza, the larger contract manufacturer active in similar drug-substance and drug-product work.

Where does Siegfried Holding Ltd sit in the AI build-out?

Siegfried holds no seat in Rubin, our AI compute index, or in Halo; it sits outside the diary's AI-linked sleeves entirely. It is tracked instead as a pharmaceutical contract manufacturer within the healthcare sector of our wider universe, not against any build-out layer. Siegfried carries no index seat and no Closelooknet score; the score-building process has not started for this name. The diary has not quoted it in any edition so far, and it appears in no Rubin or Halo reading.

Does Siegfried Holding Ltd pay a dividend?

Siegfried Holding Ltd has paid 0.40 CHF per share over the last twelve months, paid once a year, a trailing yield of 0.57% on the 2026-10-06 close; the last distribution recorded in the price series was 0.40 CHF on 2026-04-28. In fiscal 2025 the company paid 17 m CHF in dividends and bought back 1 m CHF of its own shares, 180% of that year’s free cash flow. The share count rose 0.8% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for SFZN.SW, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.